Its spine revenue reached $4.34 million, while Implanet’s other businesses, medical equipment and services, made up the rest. Spine revenue was down 4 percent from the same time last year, according to the results published July 11.
Spine revenue in the U.S. totaled just over $900,000, while the majority of revenues came from France.
At the end of the second quarter, Implanet had a cash position of $1.66 million. In the second half of the year, Implanet plans to finalize the registration of its existing products in Europe, reinvigorate its presence in the U.S., continue developing strategic partnerships with SeaSpine and initiate the distribution of a new platform in China.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
